Navigation Links
Hologic to Present at the Raymond James & Associates 29th Annual Institutional Investors Conference
Date:2/26/2008

BEDFORD, Mass., Feb. 26 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX) today announced that Glenn Muir, Chief Financial Officer, will be presenting at the Raymond James & Associates 29th Annual Institutional Investors Conference being held March 2-5, 2008 at the Hyatt Regency Grand Cypress Hotel in Orlando, FL.

Interested parties are invited to listen to a live audio webcast of Hologic's investor presentation on Monday, March 3, 2008 at 10:25 a.m. Eastern Time on the investor section of the Company's website at http://www.hologic.com/investor. An archive of the presentation will be available for replay following the conference.

About Hologic, Inc.

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic leads the industry in digital mammography systems and offers the most advanced technology for breast imaging and breast biopsy. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, osteoporosis assessment, preterm birth risk assessment, and mini C-arm for extremity imaging. For more information visit http://www.hologic.com.

Contact: Glenn P. Muir Frances Crecco

Executive Vice President and CFO Director, Investor Relations

Hologic, Inc.
'/>"/>

SOURCE Hologic, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Does Pathological Shyness Make for School Shooters?
2. U of M study: Health food supplement may curb addiction of pathological gamblers
3. Hologic Sets Special Meeting of Stockholders to Vote on Proposed Merger with Cytyc Corporation
4. Hologic to Present at the UBS Global Life Sciences Conference
5. Hologic Acquires Biolucent, Inc.
6. Hologic Chairman and CEO to Open NASDAQ Stock Market on October 2, 2007
7. ISS Recommends Hologic Stockholders Vote FOR Merger With Cytyc
8. 1 in 5 bariatric surgery candidates not psychologically cleared for surgery
9. Hologic Stockholders Approve Merger with Cytyc
10. Exercise and psychological counseling could ease cancer-related fatigue
11. Cancer care providers need to proactively address patients psychological and social needs
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 3BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 4Shanghai ChemPartner Is Pleased to be Part of Agios' Groundbreaking Cancer Research 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Availity Teams with Thomson Reuters to Integrate Treatment Cost Calculator 47491 1Availity Teams with Thomson Reuters to Integrate Treatment Cost Calculator 47491 2Researchers determine predicting factors of positive lung cancer diagnoses in chest radiographs 47488 1Findings in epilepsy gene in animals may guide treatment directions for infants 47484 1Findings in epilepsy gene in animals may guide treatment directions for infants 47484 2Findings in epilepsy gene in animals may guide treatment directions for infants 47484 3